Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Linking Individuals Needing Care for Substance Use Disorders to Peer Coaches & Across INcarceration Settings (LINCS UP & IN)

13. August 2026 aktualisiert von: Joseph Carpenter, Emory University

The goal of this study is to learn whether a virtual peer recovery coach (PRC) intervention can improve engagement in addiction treatment among incarcerated adults with substance use disorders.

The main questions it aims to answer are:

  • Does the PRC intervention increase engagement with at least one recovery resource at 30 and 90 days?
  • Does it improve secondary outcomes such as substance use, recovery capital, overdose events, and recidivism?

Researchers will compare Treatment-as-Usual with the PRC telehealth intervention to see if PRC support improves engagement in addiction care.

Participants will:

  • Complete baseline and follow-up assessments
  • Receive either Treatment-as-Usual or a virtual PRC session focused on motivational interviewing and linkage to recovery resources

Studienübersicht

Detaillierte Beschreibung

This study evaluates a virtual peer recovery coach (PRC) intervention designed to support adults with substance use disorders during incarceration and the transition back to the community. The trial is conducted across multiple jail facilities in Metro Atlanta, where individuals experience high rates of substance use disorders and limited access to treatment services. Peer recovery coaches-individuals with lived experience who are trained in motivational interviewing and linkage to care-have demonstrated benefit in healthcare settings, but their effectiveness within jail environments has not been rigorously tested.

The intervention adapts an existing virtual PRC model for use in jail settings. PRCs meet with participants through a secure telehealth platform and provide individualized support focused on motivation, readiness for change, and connection to recovery resources. The model is designed to be scalable, flexible, and responsive to the needs of individuals with diverse substance use profiles, including those for whom no FDA-approved medications exist.

The study uses a phased implementation approach in which participating jail sites transition from usual care to the PRC intervention over time. This structure allows the program to be integrated into each facility's workflow while enabling evaluation of the intervention's impact. Participants are followed for one year to assess engagement with recovery resources and other indicators of health, stability, and community reintegration.

The findings will inform whether virtual PRC services can be effectively delivered in jail settings and whether they improve connection to treatment and recovery supports during a period of heightened vulnerability. Results may guide future implementation of peer-based models in correctional systems and other high-risk environments.

Studientyp

Interventionell

Einschreibung (Geschätzt)

550

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studieren Sie die Kontaktsicherung

Studienorte

    • Georgia
      • Atlanta, Georgia, Vereinigte Staaten, 30303
        • Rekrutierung
        • Atlanta City Detention Center
      • Atlanta, Georgia, Vereinigte Staaten, 30318
        • Rekrutierung
        • Fulton County Jail
      • Decatur, Georgia, Vereinigte Staaten, 30032
        • Rekrutierung
        • Dekalb County Jail

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Ja

Beschreibung

Inclusion Criteria:

  • Incarcerated at participating jail
  • Able to speak and understand English
  • Score of 3 or greater - "moderate level", "substantial level", or "severe level" of problems related to drug abuse - on DAST-10.
  • Willing to follow study procedures and complete research follow-up calls
  • Have at least two reliable contact numbers, e.g. participant and one or more relatives or close friends

Exclusion Criteria:

  • Cognitive impairment (inability to comprehend the informed consent document as assessed by study staff during enrollment)
  • Prior participation in the study
  • Awaiting transfer to prison or jail outside the state of Georgia

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Unterstützende Pflege
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: PRC group
Participants meet virtually with a trained peer recovery coach using a secure telehealth platform. PRCs use motivational interviewing, assess readiness to change, and provide individualized linkage to recovery resources. Support may include connection to medications for opioid use disorder, residential treatment, detoxification centers, harm reduction services, mutual support groups, sober living, or recovery community organizations. PRCs may also conduct post-release check-ins to support ongoing engagement.
A telehealth session with a peer recovery coach who provides motivational interviewing and tailored linkage to addiction treatment and recovery resources.
Aktiver Komparator: Standard of Care
Participants receive the jail's standard approach to substance use support. This includes a review of available community treatment and recovery resources consistent with existing facility practices. No peer recovery coach is involved, and no additional study-driven services are provided.
Participants are provided information about community-based addiction treatment and recovery resources as part of routine jail processes.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Engagement With at Least One Recovery Resource
Zeitfenster: 30 days and 90 days after enrollment

Engagement with at least one recovery resource, defined as:

  • Formal addiction treatment (visit with a physician, psychologist, or licensed substance use counselor; or ≥1 night in detoxification or residential treatment), or
  • Recovery Community Organization (RCO) participation (contact, intake, and participation in ≥1 evidence-based recovery activity), or
  • Harm reduction organization engagement. Engagement may occur during incarceration or in the community after release.
30 days and 90 days after enrollment

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Days Receiving Medications for Substance Use Disorders
Zeitfenster: Baseline to 30 days, 90 days, 180 days, and 1 year
Number of days participants receive medications for opioid use disorder (MOUD), stimulant use disorder, or alcohol use disorder.
Baseline to 30 days, 90 days, 180 days, and 1 year
Recidivism and Justice Involvement
Zeitfenster: Baseline to 1 year
New arrests, bookings, or jail stays documented through participant report or administrative data.
Baseline to 1 year
Healthcare Utilization
Zeitfenster: Baseline to 1 year
Emergency department visits, hospitalizations, and other acute care encounters.
Baseline to 1 year
Recovery Capital (BARC-10)
Zeitfenster: Baseline, 30, 90, 180 days, and 1 year

Brief Assessment of Recovery Capital (BARC-10) A 10-item validated scale that measures a person's internal and external resources that support recovery from substance use. Items assess domains such as social support, coping skills, housing stability, and personal motivation.

  • Scores range from 10 to 60.
  • Higher scores indicate greater recovery capital and stronger readiness to sustain recovery.
Baseline, 30, 90, 180 days, and 1 year
Number of Peer Recovery Coach Contacts
Zeitfenster: Baseline to 30 days, 90 days, 180 days, and 1 year
Number of PRC interactions among participants assigned to the intervention arm.
Baseline to 30 days, 90 days, 180 days, and 1 year
Self-Reported Substance Use (TLFB)
Zeitfenster: Baseline, 30, 90, 180 days, and 1 year
Days of substance use in the past 30 days using the Timeline Follow-Back method. A structured calendar-based interview used to measure self-reported substance use over the past 30 days. Participants recall days of use using memory anchors (events, routines).
Baseline, 30, 90, 180 days, and 1 year
Fatal Overdose Events
Zeitfenster: Baseline through 1 year
Overdose events identified through participant report, medical records, or community partner data.
Baseline through 1 year
Nonfatal Overdose Events
Zeitfenster: Baseline through 1 year
Overdose events identified through participant report, medical records, or community partner data.
Baseline through 1 year
Housing status
Zeitfenster: Baseline, 30, 90, 180 days, and 1 year
Current housing status (stable, unstable, homeless)
Baseline, 30, 90, 180 days, and 1 year
Employment status
Zeitfenster: Baseline, 30, 90, 180 days, and 1 year
Employment status (full-time, part-time, unemployed)
Baseline, 30, 90, 180 days, and 1 year
Social connections and Isolation: PROMIS scale
Zeitfenster: Baseline, 30, 90, 180 days, and 1 year

A validated set of items assessing perceived social support, loneliness, and connectedness.

  • Generates T-scores standardized to the U.S. population (mean = 50, SD = 10).
  • Higher scores on Social Support = more support.
  • Used to evaluate social determinants of recovery.
Baseline, 30, 90, 180 days, and 1 year
All-Cause Mortality
Zeitfenster: Baseline through 1 year
Death from any cause, confirmed through vital records or the National Death Index.
Baseline through 1 year

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Joseph Carpenter, MD, Emory University

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. September 2026

Primärer Abschluss (Geschätzt)

1. März 2030

Studienabschluss (Geschätzt)

1. März 2030

Studienanmeldedaten

Zuerst eingereicht

22. April 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

29. April 2026

Zuerst gepostet (Tatsächlich)

4. Mai 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

17. August 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

13. August 2026

Zuletzt verifiziert

1. August 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • 2025P012936
  • 1R01DA064519-01 (US NIH Stipendium/Vertrag)

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren